Search Results for: DOZ

DOZ chain will be able to take over Euro-Apteka
|

DOZ chain will be able to take over Euro-Apteka

The President of the Office of Competition and Consumer Protection (UOKiK) has authorised the takeover of Euro-Apteka, Super Zdrowie and MLV18 by DOZ, on condition that the chain sells one of its pharmacies. This decision was dictated by compliance with the provisions of the Competition and Consumer Protection Act. The conditional consent to the acquisition…

Will DOZ close 12 pharmacies in Podlasie?

Will DOZ close 12 pharmacies in Podlasie?

The Voivodship Pharmaceutical Inspectorate (WIF) in Podlasie issued a decision concerning 12 pharmacies belonging to the DOZ pharmacy chain. The decision is a response to the ZAPPA’s request for a breach of the anti-concentration limit. 6 months to correct the irregularities The WIF decision indicates that 12 DOZ companies constitute a capital group which operates…

Biosimilar medicines: Sandoz will comercialise Polpharma’s SM drug
| |

Biosimilar medicines: Sandoz will comercialise Polpharma’s SM drug

Polpharma Biologics and global generic giant Sandoz will jointly launch a biosimilar to the multiple sclerosis (SM) biological drug. This is the result of a contract signed last Tuesday for the commercialisation of the product. Polpharma will fight for a billion-dollar market Polpharma is developing a biosimilar to the Tysabri drug (natalizumab) produced by Biogen…

Orpea Polska: A dozen or so new outlets
|

Orpea Polska: A dozen or so new outlets

Orpea Polska, which operates a network of nursing homes and rehabilitation clinics, plans to open new centres and increase the number of places to 2,000 over the next few years. Orpea’s investments will focus on Warsaw Orpea Polska will build nursing homes under the name of Orpea Rezydencje, and rehabilitation clinics under the name of…

DOZ chain of pharmacies will acquire Medix
|

DOZ chain of pharmacies will acquire Medix

DOZ SA submitted an application to the Office of Competition and Consumer Protection for permission to take over Medix Sp. z o.o. DOZ SA operates the largest chain of pharmacies in Poland. The acquired entity has its registered office in Tczew. It has 18 active pharmacies which already operate under the name DOZ. According to…

Medicover acquires Medicus CDT Group 

Medicover acquires Medicus CDT Group 

Medicover has agreed to purchase the CDT Medicus Group, a prominent private healthcare provider in Legnica-Glogow. Medicover’s portfolio will grow by numerous medical facilities, including two hospitals and more than a dozen outpatient clinics, as a result of this investment. The deal still must be approved by the Office of Competition and Consumer Protection before…

THC Pathfinder wants to revolutionise pharmaceutical manufacturing
|

THC Pathfinder wants to revolutionise pharmaceutical manufacturing

NaturalAntibody, a company co-founded by THC Pathfinder, wants to reduce the time to manufacture antibody-based drugs by automating research. One of the first companies interested in the innovative approach is AstraZeneca, with further potential partners coming from major biotech hubs such as Cambridge, Oxford, and Boston. Tar Heel Capital Pathfinder (THC) is a company that…

New Alzheimer’s drug approved in the US

New Alzheimer’s drug approved in the US

The US Food and Drug Administration (FDA) grants expedited approval to Biogen to market its Alzheimer’s drug in the US. The drug in question is Aducanumab, also known as Aduhelm, which is the first Alzheimer’s drug approved since 2003. Biogen’s drug for Alzheimer’s is a breakthrough in medicine The US Food and Drug Administration (FDA) approved…

Satis Group invests strongly in health
| |

Satis Group invests strongly in health

Myneviskin Sp. z o.o, whose investor is Satis Group, has signed an agreement with Puwer Polska, which specialises in medical marketing, concerning a scanner for early diagnosis of skin cancer. The solution is to hit the commercial market by the end of June. Moreover, it is possible that Satis Group will also open infertility treatment…